CLINICAL_TRIALS
trial_result
· 2022-01-27
Clinical Trial Update: Optimal Dosage of Ticagrelor in Korean Patients With AMI [Phase 4]
Summary
A Phase 4 trial update investigating the optimal dosage of ticagrelor in Korean patients with acute myocardial infarction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-A University | Conditions: Acute Myocardial Infarction, Ticagrelor | Phase 4 | Status: UNKNOWN